Lilly inks $3.2B Morphic buyout to take on Takeda in IBD - Fierce Biotech

1. Lilly inks $3.2B Morphic buyout to take on Takeda in IBD  Fierce Biotech
2. Eli Lilly to Buy Morphic Holding for $3.2 Billion  The Wall Street Journal
3. Lilly Agrees to Buy US Biotech Morphic in $3.2 Billion Deal  Yahoo Finance
4. Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease | Eli Lilly and Company  Investors | Eli Lilly and Company